InvestorsHub Logo
Followers 13
Posts 865
Boards Moderated 0
Alias Born 02/17/2017

Re: The Lawman post# 36611

Saturday, 02/16/2019 10:00:46 PM

Saturday, February 16, 2019 10:00:46 PM

Post# of 232880
Legitimate question... Since at least mid-2017, there have been nonpublic preclinical trials and/or discussions going on with Pestell and Prostagene at a minimum. Do you think that Pourhassan, or any other member of the board or management, could actually buy on the open market while actively in possession of material nonpublic information, or even in active M&A discussions? I’m no securities lawyer and I certainly don’t know the answer, but I imagine the prohibitions would be strict.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News